| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |